![]() |
|
|
Vol. 54, Issue 5, 789-801, November 1998
Faculty of Biology, Chair of Molecular Toxicology, University of Konstanz, D-78457 Konstanz, Germany
| |
Summary |
|---|
|
|
|---|
The pathogenesis of several neurodegenerative diseases may involve indirect excitotoxic mechanisms, where glutamate receptor overstimulation is a secondary consequence of initial functional defects of neurons (e.g., impairment of mitochondrial energy generation). The neurotoxin 1-methyl-4-phenylpyridinium (MPP+) and other mitochondrial inhibitors (e.g., rotenone or 3-nitropropionic acid) elicited apoptosis in cerebellar granule cell cultures via stimulation of autocrine excitotoxicity. Cell death, increase in intracellular Ca2+ concentration, release of cytochrome c, and all biochemical and morphological signs of apoptosis were prevented by blockade of the N-methyl-D-aspartate receptor with noncompetitive, glycine-site or glutamate-site inhibitors. In addition, MPP+-induced apoptosis was reduced by high Mg2+ concentrations in the medium or by inhibiting exocytosis with clostridial neurotoxins. Two classes of cysteine proteases were involved in the execution of cell death: caspases and calpains. Inhibitors of either class of proteases prevented cell death, cleavage of intracellular proteins (i.e., fodrin), and the appearance of typical features of apoptosis such as phosphatidylserine translocation or DNA fragmentation. However, protease inhibitors did not interfere with the initial intracellular Ca2+ concentration increase. We suggest that MPP+ as well as other mitochondrial inhibitors trigger indirect excitotoxic processes, which lead to Ca2+ overload, protease activation, and subsequent neuronal apoptosis.
| |
Introduction |
|---|
|
|
|---|
Excitotoxic
mechanisms (i.e., excessive stimulation of glutamate receptors with a
resultant disturbance of cellular
[Ca2+]i homeostasis) may
be involved in stroke and possibly in slowly developing
neurodegenerative diseases (Choi and Rothman, 1990
). However, glutamate
receptor stimulation is rarely a primary event in neurotoxicity.
Glutamate release and glutamate-triggered excitotoxicity are rather
secondary consequences of other defects or metabolic disturbances. A
frequent initiating condition is energy depletion, and mitochondrial
dysfunction is among the most generalized causes favoring the
development of different neurodegenerative diseases (Beal, 1996
). For
example, Huntington's disease is modeled by exposing specific neuronal
subpopulations to mitochondrial toxins (Ferrante et al.,
1997
), and ischemic damage can be examined in vitro after
mitochondrial substrate depletion due to oxygen/glucose deprivation
(Choi and Rothman, 1990
).
In these models, a close relationship has been established between
energy deficiency and excitotoxicity. The ATP loss resulting from
decreased mitochondrial energy generation would lead to impaired function of ion pumps and partial hypopolarization of neurons, thereby
releasing the voltage-dependent Mg2+ block of the
NMDA-R-gated Ca2+ channel. This would make the
receptor/channel hypersensitive to glutamate stimulation.
NMDA-R-mediated influx of Na+ and
Ca2+ then would increase energy demand and ATP
depletion, enhance depolarization, trigger further
[Ca2+]i increase, and
eventually result in further glutamate release. This putatively
self-propagating process finally leading to a loss of
[Ca2+]i homeostasis and
excitotoxicity has been termed the "energy-linked excitotoxicity
hypothesis" (Henneberry et al., 1989
; Zeevalk and Nicklas,
1990
). Distal mechanisms (downstream of
[Ca2+]i increase) leading
to neuronal death under such conditions may differ from those operating
after simple glutamate receptor stimulation and are largely unknown.
Excitotoxicity may lead to either necrosis or to a more ordered
sequence of molecular events resulting in apoptosis (Ankarcrona et al., 1995
; Leist and Nicotera, 1998
). Recent work in our
laboratory has shown caspase activation downstream to the initial
[Ca2+]i increase in a
model of indirect excitotoxicity, where NMDA-R activation was triggered
by NO (Leist et al., 1997a
, 1997d
). In parallel, studies
in vivo have suggested that caspases may be involved in
neuronal damage after stroke (Loddick et al., 1996
). In all
these models, the exact primary insult is little characterized and
possibly not limited to mitochondrial dysfunction; therefore, it is
still unclear how a primary mitochondrial impairment can lead to
excitotoxic apoptosis.
The neurotoxin MPTP induces a Parkinson's disease-like syndrome in
humans and animals via its active metabolite,
MPP+ (Tipton and Singer, 1993
). Although
MPP+ affects only certain neurons in
vivo due to pharmacokinetic reason, the substance inhibits
mitochondrial function in any cultured neuronal or non-neuronal cell or
isolated mitochondria. A known molecular target of
MPP+ is the mitochondrial respiratory chain
complex I (NADH-ubiquinone-oxidoreductase) (Nicklas et al.,
1985
; Kilbourn et al., 1997
), and no other main target has
been characterized to date, despite extensive studies. In
vivo (i.e., in the presence of glutamatergic cortical inputs), the
primary impairment of mitochondrial respiration by
MPP+ sensitizes neurons to secondary excitotoxic
damage. Thus, blockade of glutamate receptors (Turski et
al., 1991
; Srivastava et al., 1993
) or prevention of
the synthesis of endogenous NO (Schulz et al., 1995
;
Hantraye et al., 1996
), a mediator closely linked to
excitotoxicity, has been found to reduce MPP+
toxicity in animals.
In the current study, we exposed neurons to the mitochondrial poison
MPP+ or other respiratory chain inhibitors. CGC
have been shown to be susceptible to MPP+ (Marini
et al., 1989
). Thus, we used here neuronal cultures, which
mimic the very high density of excitable glutamatergic synapses present
in vivo. Densely plated CGC, differentiated for
8 days in
K+-supplemented medium, represent an ideal
culture system for this purpose. We examined in this culture system (i)
whether excitotoxic mechanisms contribute to MPP+
toxicity, (ii) whether such excitotoxicity results in apoptosis, (iii)
under which conditions the execution of excitotoxic death triggered by
MPP+ or other mitochondrial toxins involves
caspases, and (iv) which apoptotic features depend on the activity of
protease families activated by excitotoxic disruption of
[Ca2+]i homeostasis.
| |
Experimental Procedures |
|---|
|
|
|---|
Materials. Fluo 3-acetoxymethyl ester, Fura 2-acetoxymethyl ester, calcein acetoxymethyl ester, TMRE, SYTOX, ethidium homodimer-1, and H-33342 were obtained from Molecular Probes (Eugene, OR). The caspase substrate DEVD-afc, MPP+, DCK, DNQX, and 6,7-dichloroquinoxaline-2,3-dione were obtained from BIOMOL (Hamburg, Germany). MK801 came from RBI (Biotrend Chemikalien GmbH, Köln, Germany). succ-LLVY-amc; calpain inhibitors I, II, and III (Ac-Leu-Leu-L-norleucinal, Ac-Leu-Leu-L-methional, and calp III, z-Phe-chloromethylketone (cmk); and the caspase-inhibitors DEVD-CHO, z-VAD-fluoromethylketone (fmk), Ac-YVAD-cmk, or Ac-YVAD-2,6-dimethylbenzoyloxymethylketone (ICE II) and z-D-2,6-dichlorobenzoyloxymethylketone (cbk) (ICE III) were obtained from Bachem Biochemica (Heidelberg, Germany). DEVD-fmk was from Enzyme Systems (Dublin, CA). Fluorescein-labeled annexin V (annexin V) was from Boehringer-Mannheim (Mannheim, Germany). Clostridial toxins were generously supplied by Dr. C. Montecucco (University of Padova, Padova, Italy). Solvents and inorganic salts were from Merck (Darmstadt, Germany) or Riedel-de Haen (Seelze, Germany). All other reagents not further specified were from Sigma (Deisenhofen, Germany).
Animals.
PARP
/
mice (C57Bl/6 × 129/Sv background) or corresponding wild-type animals were
generously provided by Dr. Zhao-Qi Wang (IARC, Lyon, France) (Wang
et al., 1995
). All animals used for cell preparations were
typed by Southern blotting (Wang et al., 1995
) to verify the
genotype. For other experiments, 8-day-old specific pathogen-free BALB/c mice were obtained from the Animal Unit of the University of
Konstanz. All experiments were performed in accordance with international guidelines to minimize pain and discomfort (National Institutes of Health guidelines and European Community Council Directive 86/609/EEC).
Cell culture.
Murine CGC were prepared as described
previously (Schousboe et al., 1989
). Neurons were plated
onto 100 µg/ml (250 µg/ml for glass surfaces)
poly-L-lysine (molecular mass, >300 kDa)-coated dishes at
a density of ~0.25 × 106
cells/cm2 (800,000 cells/ml; 500 µl/well;
24-well plate) and cultured in Eagle's basal medium (GIBCO, Paisley,
Scotland) supplemented with 10% heat-inactivated fetal calf serum, 20 mM KCl, 2 mM L-glutamine, 100 units/ml penicillin, and 100 µg/ml streptomycin. Forty-eight hours after plating, cytosine arabinoside (10 µM) was
added to the cultures. Neurons were routinely used at 8-10 DIV unless
otherwise indicated. Glial fibrillary acid protein-positive cells were
<5%.
Cytotoxicity assays. Cultures were exposed to MPP+ or rotenone in their own medium. The culture medium was exchanged for a CSS (120 mM NaCl, 25 mM HEPES, 25 mM KCl, 1.8 mM CaCl2, 4 mM MgCl2) plus 15 mM glucose 4 hr after the start of the incubation, and the cells were left in this medium until toxicity parameters were read (usually 18 hr for MTT or nuclear morphology). Inhibitors were added routinely 30 min before exposure to MPP+.
To assess plasma membrane integrity and nuclear morphology, CGC were loaded with 0.5 µM calcein acetoxymethyl ester for 5 min (cells with intact membranes display green fluorescence) in the presence of 1 µM ethidium homodimer-1 (cells with broken membranes exhibit nuclear red fluorescence) and 500 ng/ml concentration of the bisbenzimide dye H-33342 (cell permeant, blue-fluorescent). Alternatively, apoptosis and secondary lysis were quantified by double staining neuronal cultures with 1 µg/ml H-33342 and 0.5 µM SYTOX (non-cell-permeant, green-fluorescent chromatin stain). Apoptotic cells were characterized by condensed highly fluorescent nuclei. About 600-1000 cells were counted in nine different fields in two or three different culture wells, and experiments were repeated in at least three different preparations. In addition, the percentage of viable cells was quantified by their MTT-reducing capacity after incubation with 0.5 mg/ml MTT for 60 min. The viability of untreated control cultures was set to 100%, and the viability of treated cultures was expressed as percentage of formazan absorbance compared with that of control cultures.Ca2+ measurements.
The
[Ca2+]i was measured by
imaging neurons loaded with fluorescent Ca2+
indicators. To monitor dynamic changes of Ca2+,
CGC were loaded in their original medium with 1 µM fluo-3
acetoxymethyl ester for 10 min at 37°. The medium then was exchanged
for CSS, in which CGC were incubated for 5 min to allow complete
de-esterification of fluo-3. The medium was exchanged again for the
original neuron-conditioned complete Eagle's basal medium supplemented
with 20 mM HEPES (MPP+ as stimulus)
or for CSS (without Mg2+) (50 µM
glutamate or 200 µM NMDA as stimulus) or for CSS plus 2 µM MK801 (200 µM kainate as stimulus). CGC
were allowed to equilibrate at room temperature for 10 min before the
exposure. Images were collected using the 488-nm excitation and 520-nm
emission wavelengths and a Leica DM-IRB microscope equipped with a 40×
NA 1.0 lens. Data from 10-20 neurons were recorded at 3-60-sec
intervals with a Leica TCS 4D confocal system. Relative mean
fluorescence levels from defined areas corresponding to the position of
neuronal cell bodies were recorded over the time course of the
experiment, and the values were arbitrarily set to 1 at the beginning
of each experiment. To determine absolute
[Ca2+]i, we used the low
Kd indicator Fura 2-acetoxymethyl
ester (2.5 µM; Molecular Probes, Eugene, OR),
which reports [Ca2+]i
exactly in the low concentration range (
500
nM). This allowed us to examine whether MK801
would maintain [Ca2+]i to
base-line levels in MPP+-treated cells. A Leica
M-IRB microscope equipped with a computer-controlled filter wheel
(Sutter, Novato, CA), quartz optics, and a Dage-72 (Dage-MTI; Michigan
City, IN) charge-coupled device (CCD) camera [756 (H) × 581 (V)
pixels] coupled to a videoscope GEN-III image intensifier was used for
imaging (
ex-1 = 340 nm,
ex-2 = 380 nm,
em = 505 nm). Videomicroscopy data were analyzed using software from Imaging
Research (St. Catherine's, Ontario, Canada).
[Ca2+]i was determined by
in situ calibration using the equation
[Ca2+]i = Kd × (R
Rmin)/(Rmax
R) × Sf2/Sb2,
with Kd(25°) = 264 nM. To determine
Rmin, cells were washed twice with
calibration buffer (120 mM NaCl, 25 mM HEPES, 15 mM glucose, 25 mM KCl, 2 mM
MgCl2, 2 mM EGTA) and
equilibrated for 20 min in calibration buffer supplemented with 5 µM ionomycin. Ca2+ (5 mM) and ionomycin (10 µM)
were added to saturate Fura-2 with Ca2+ and
calculate Rmax. Autofluorescence was
measured after the addition of 5 mM
MnCl2.
Electrophoretic assays. Fodrin proteolysis was analyzed by immunoblot. CGC cultures were lysed in RIPA buffer (150 mM NaCl, 50 mM Tris, 1% Nonidet P-40, 0.25% sodium deoxycholate, 1 mM EGTA) supplemented with protease inhibitors (1 mM phenylmethylsulfonyl fluoride, 1 mM benzamidine, 1 mM iodoacetate, 1 mM iodoacetamide, 40 µM leupeptin, 10 µg/ml antipain, 5 µg/ml pepstatin). Before lysis, cultures were stained with 0.5 µM SYTOX to control the percentage of cells with intact membranes, which was >95% for all samples analyzed. Protein was determined using the bicinchoninic acid method (BioRad, München, Germany), and 5 µg of protein/lane was loaded onto 8% polyacrylamide gels. Proteins were separated under reducing conditions at 60 mA and then blotted onot a nitrocellulose membrane (Amersham-Buchler, Braunschweig, Germany) in a BioRad semidry blotter at 2.6 mA/cm2 for 50 min using a Towbin buffer system. Blots were blocked for 1 hr and then incubated with anti-fodrin monoclonal antibody (clone 1622, 1:1000) from Chemicon (Temecula, CA) diluted in TNT (150 mM NaCl, 50 mM Tris, pH 8.0, 0.05% Tween 20) for 1 hr at room temperature. Specifically stained bands were detected by enhanced chemiluminescence (Amersham) using a peroxidase-coupled secondary antibody. For Western blot analysis of procaspase-3 (14% gel, 60 µg of neuronal protein/lane), we used a primary rabbit anti-human procaspase-3 polyclonal antibody (1:1000, no. 06753; Upstate Biotechnology, Lake Placid, NY) recognizing the 32-kDa murine procaspase but not the cleavage products.
Field inversion gel electrophoresis was performed as described previously (Ankarcrona et al., 1995
-DNA concatemers (n × 50 kbp) were used as molecular weight markers.
Mitochondrial function and integrity.
ATP was measured
luminometrically after lysis of cells in ATP-releasing agent (Sigma)
with a commercial kit (Boehringer-Mannheim) as described previously
(Leist et al., 1997c
). The 
was monitored by loading
cells with the fluorescent indicator TMRE (5 nM:
ex, 568 nm;
em,
590
nm). Under these conditions, fluorescence completely disappeared on
loss of 
(50 µM glutamate or 50 µM
CCCP) in neurons that retained plasma membrane integrity. For the
experiments, at least three culture dishes were imaged in at least six
cell preparations for each data point presented. For semiquantitative analysis of 
, we added red fluorescent beads of 2-µm diameter and calibrated fluorescence intensity (Molecular Probes, Eugene, OR) to
the cultures. The standardized fluorescence of the beads was used as an
internal standard to normalize the fluorescence intensities of
digitized images of TMRE-loaded neurons. The fluorescence of neurons
treated with 20 µM CCCP was used as reference for
depolarized mitochondria.
|
Enzymatic assays.
Caspase-3-like activity (measured by
DEVD-afc cleavage) was assayed as described previously (Leist et
al., 1997b
) with the following modifications: CGC were pelleted in
PBS supplemented with 5 mM EDTA, 1 µg/ml leupeptin, 1 µg/ml pepstatin, 1 µg/ml aprotinin, and 1 mM
PEFA-block. Lysis was performed in 25 mM HEPES, 5 mM MgCl2, 1 mM EGTA,
0.5% Triton X-100, 1 µg/ml leupeptin, 1 µg/ml pepstatin, 1 µg/ml
aprotinin, and 1 mM PEFA-block, pH 7.5. The fluorimetric
assay was carried out in microtiter plates with a substrate
concentration of 40 µM and a total protein amount of 5 µg. Cleavage of DEVD-afc was followed in reaction buffer (50 mM HEPES, 10 mM dithiothreitol, 1% sucrose,
0.1% 3-[(3-cholamidopropyl)dimethylammonio]propanesulfonate) over a
period of 30 min at 37° with
ex = 390 nm and
em = 505 nm, and the activity was calibrated
with afc-standard solutions. Calpain activity was determined by a
kinetic fluorimetric assay as described previously (Leist et
al., 1997d
). Glucose concentrations in the medium were determined
according to the hexokinase/glucose dehydrogenase method using a
commercial kit (Sigma).
Visualization of PS translocation. Cells stained with different fluorescent probes were imaged on a Leica DM-IRBE microscope equipped with a computer-controlled z-stage and connected to a TCS-4D UV/VIS confocal scanning system (Leica AG, Benzheim, and Leica Lasertechnik, Heidelberg, Germany). The staining protocol for fluorescein-conjugated annexin V (detection of PS on the outer leaflet of the plasma membrane) was adapted for neuronal cultures as follows: CGC were grown on glass-bottomed culture dishes and incubated with MPP+ or rotenone with or without inhibitors. At the end of the incubation periods, 0.5 µg/ml H-33342 was added to the cultures to later visualize chromatin structure. After a 10-min incubation at 37°, CGC were washed for 10 sec with binding buffer (10 mM HEPES, 140 mM NaCl, 2.5 mM CaCl2, 10 mM MgCl2) and subsequently incubated for 2 min in the dark with annexin V diluted 1:100 in binding buffer. After a new wash with binding buffer, stained cultures were immersed in binding buffer supplemented with 0.25 µM ethidium homodimer-1 and visualized by three-channel confocal microscopy (blue, chromatin structure, green, annexin binding, red, membrane integrity) using a 63×/NA 1.32 UV-corrected lens.
Statistics. Toxicity experiments were run in triplicate and repeated in three to eight cell preparations. Statistical significance was calculated on the original data sets using the Student's t test. When variances within the compared groups were not homogeneous, the Welch test was applied. Western blots and measurements of [Ca2+]i were repeated in at least three independent cell preparations.
| |
Results |
|---|
|
|
|---|
A role for the NMDA-R in MPP+-induced CGC
apoptosis.
MPP+ caused apoptosis of
differentiated (8 DIV) CGC in a concentration range of 25-100
µM (Fig. 1). Toxicity of
MPP+ was evident in cells exposed to
MPP+ for 2-4 hr, unlike the slow toxicity
observed in an earlier report (Marini et al., 1989
).
Susceptibility of CGC to such rapidly developing MPP+-induced apoptosis was strongly dependent on
the cell differentiation state. CGC were hardly sensitive toward
MPP+ during the first 2 DIV, whereas they became
progressively more susceptible to induction of apoptosis elicited by
MPP+ with increasing time in culture, as
described elsewhere for other excitotoxic stimuli (i.e., NMDA, NO, or
ONOO
) (Leist et al., 1997a
) (Fig.
1).
|
120 µM) (Fig. 2A). In
the presence of MK801, MPP+ also caused no
significant cell death when neurons were continuously exposed for 18 hr. Long preincubation with MK801 was not required because the channel
blocker still protected MPP+-challenged neurons
when it was added up to 15 min after the exposure to
MPP+. Neurons challenged for 4 hr with 50 µM MPP+ in the presence of MK801
and then cultured in conditioned medium without
MPP+ for an additional 96 hr were virtually
unaffected (
95% viable). In contrast, CGC exposed permanently to
MPP+ at concentrations of
50 µM,
in the presence of MK801, showed signs of degeneration after 24 hr and
died after 36-72 hr. This suggests that chronic exposure of CGC to
MPP+ resulted in the activation of additional,
nonexcitotoxicity mechanisms.
|
50 µM points to
the predominant role of the NMDA-activated subtype of glutamate receptors for this effect. DCK, the most selective inhibitor of the
NMDA-R glycine site tested here, also was most potent in inhibiting MPP+-induced CGC apoptosis. This further suggests
a role for the NMDA-R and excitotoxicity in
MPP+-induced CGC apoptosis.
Activation of VDCC has been shown to contribute significantly to
NMDA-triggered neuronal
[Ca2+]i increase
(reviewed in Leist and Nicotera, 1997Rapid ATP depletion as a possible trigger of MPP+
excitotoxicity.
Because energy depletion is known to trigger
excitotoxic processes in different experimental systems, we examined
intracellular ATP levels after treatment of CGC with
MPP+. ATP declined slowly during the first 30 min
of treatment with MPP+, and it was dissipated
90% after 3-4 hr. Treatment with MK801 delayed the loss of ATP by
30-60 min; however, at 3-4 hr after exposure to
MPP+, ATP also was depleted in these cells (Fig.
3A). These findings suggest that
MPP+ caused a primary ATP depletion that was
largely independent of the secondary excitotoxicity. This also implied
that ATP depletion alone was not immediately lethal to neurons but
rather sensitized them to glutamate and facilitated glutamate release.
Under our culture conditions (residual glucose concentrations of ~1
mM in the medium), glycolytic ATP production alone was not
sufficient to maintain intracellular ATP concentrations at control
levels after exposure to MPP+. Accordingly, the
addition of 10 mM glucose delayed
MPP+ toxicity, which suggests that glycolysis
remained functional. Also, when we measured the glucose consumption of
neurons, the basal rate of 20 nmol/106 cells/hr
increased to ~400 nmol/106 cells/4 hr in the
presence of MPP+, regardless of whether MK801 was
included in the culture dish.
|
Prevention of mitochondrial damage by NMDA-R block.
In this
system, MPP+ may damage mitochondria by two ways:
(i) by direct radical-induced damage and (ii) by triggering
excitotoxicity, which results in Ca2+ overload
and subsequent mitochondrial failure. We distinguished between these
two mechanisms by comparing MPP+-triggered
mitochondrial effects in the presence and absence of NMDA-R blockers.
First, changes in 
were examined by staining CGC with the
mitochondrial potential-sensitive dye TMRE (Fig. 3B). CGC pretreated
with MK801 (Fig. 3B) or AP5 (not shown) and then exposed to
MPP+ showed no significant loss of 
. In
neurons exposed to MPP+ alone, ATP depletion was
paralleled by a complete loss of 
, in analogy with a model of
direct excitotoxicity (Ankarcrona et al., 1995
). Thus, loss
of 
seemed to be due to indirect excitotoxicity and preceded
nuclear condensation and loss of membrane integrity. MPP+-induced loss of TMRE fluorescence was
selective for neurons because astrocytes within the same culture dish
lost neither TMRE fluorescence nor viability. To confirm this finding,

also was monitored with the indicators JC-1 (Ankarcrona et
al., 1995
) and Mito-Tracker Red (CMX-rosamine). All dyes yielded
similar results, but TMRE was most convenient for routine measurements
because it was less photolabile than JC-1 and more suitable for
monitoring long time periods (24 hr) than CMX-Ros, which reacts with
cellular thiols.
NMDA-R block inhibits loss of mitochondrial membrane potential and
toxicity triggered by classic mitochondrial inhibitors.
In view of
these findings, we considered that NMDA-R-dependent toxicity might be
triggered by other compounds affecting mitochondria. To evaluate this
possibility, we exposed CGC to low concentrations of mitochondrial
poisons such as oligomycin, CCCP, or rotenone. The latter blocks the
respiratory chain at a site similar to that affected by
MPP+ (Kilbourn et al., 1997
). Toxicity
of oligomycin, CCCP, or rotenone was significantly (
50% in all
cases) reduced/delayed by MK801 (not shown). Pretreatment with MK801
completely prevented the toxicity of low concentrations of rotenone
(25-50 nM) and maintained 
in short term incubation
(Fig. 3D).

was maintained long after the ATP
depletion. Residual cytosolic ATP or alternative energy substrates
likely contributed to the maintenance of 
. This is suggested by
the finding that 
was dissipated when mitochondrial inhibitors
were added together with deoxyglucose. Nevertheless, also when both

loss and ATP depletion occurred, CGC were protected by MK801.
Loss of 
triggered by the complex I inhibitor
MPP+ could be partially prevented by energizing
mitochondria with the complex II substrate methylsuccinate (Table 1).
The role of NO generation and exocytosis in MPP+
toxicity.
Endogenous NO production contributes to MPTP-induced
pathology in vivo (Hantraye et al., 1996
). Thus,
we tested whether endogenously formed NO was involved in our system.
Inhibitors of the neuronal NO synthase did not reduce
MPP+-induced apoptosis, nor did they modify other
cytotoxicity parameters (Fig. 2A). One mechanism potentially involved
in neuronal excitotoxic death is the activation of the enzyme PARP
downstream to NO-mediated DNA damage (Zhang et al., 1994
).
The mechanism of MPP+-induced excitotoxicity in
CGC was, however, unrelated to PARP activation because neurons prepared
from PARP
/
mice were equally sensitive as
those from wild-type mice (Fig. 1). Together, these findings suggested
that MPP+ has the potential to activate
excitotoxic mechanisms independent of NO generation.
(Leist et al., 1997a
-Aminoadipic acid (250 µM) significantly accelerated or enhanced
MPP+-induced CGC apoptosis (not shown).
|
|
The role of proteases in MPP+- or rotenone-induced
autocrine excitotoxicity.
To further characterize the steps
between NMDA-R-mediated
[Ca2+]i increase and cell
death, we examined the role of cellular thiol proteases. Inhibition of
either caspases or calpains was sufficient to block apoptosis elicited
by MPP+ concentrations up to 50 µM
(Fig. 6, A and B). The same set of inhibitors also protected CGC from the apoptosis induced by 50 nM rotenone (
80% cells remained viable in the presence
of each of five different protease inhibitors) (Fig. 6E). Because all available inhibitors lack an absolute specificity for a single type of
proteases (Villa et al., 1997
), we used three or five structurally different agents for each class of proteases with similar
results. Inactive control peptides (
100 µM) with
similar end groups as the inhibitors were not effective. We also
established sensitive in vitro assays with purified calpain
or recombinant caspase-3 to test cross-reactivity of the inhibitors
between the two classes of thiol proteases: for instance,
z-D-cbk was found to be a highly potent inhibitor of
caspase-3 (IC50 < 200 nM) without any inhibitory effect on calpains (IC50 > 200 µM). Calp II showed exactly opposite
characteristics. Thus, both caspases and calpains seemed to be required
to mediate apoptosis of CGC challenged with 50 µM
MPP+. Cells protected by protease inhibitors
remained viable for
24 hr, when they received new medium or CSS. At
very high intensities of insult (e.g., 100 µM
MPP+; >4-hr toxin exposure), the protective
effect of protease inhibitors was bypassed.
|
Protease inhibitors act downstream to the Ca2+ influx via the NMDA-R. Two sets of experiments were performed to test whether protease inhibitors indeed acted downstream of NMDA-R-mediated [Ca2+]i increase. First, we measured NMDA-R-mediated [Ca2+]i increases in CGC in the presence of protease inhibitors. None of the peptide inhibitors had a significant inhibitory effect (Fig. 7). Similar experiments were performed using as agonists glutamate, kainate, or high [K+]. None of the protease inhibitors blocked [Ca2+]i increase due to these stimuli (not shown).
|
The role of proteases and the NMDA-R in MPP+-induced
chromatin breakdown.
Caspase-3 activation has recently been shown
to be a direct upstream mechanism leading to oligonucleosomal
DNA-fragmentation. In CGC, oligonucleosomal DNA fragmentation was not
significantly activated within the first 4 hr after challenge, when
most other processes relevant to cell death had already occurred. In
glutamate-challenged CGC oligonucleosomal DNA fragmentation is a late
event and may not be evident at all (Ankarcrona et al.,
1995
). In analogy with the glutamate model, we observed here high
molecular weight DNA fragmentation into 600-, 300-, and 50-kbp
fragments in CGC treated with MPP+. This
characteristic feature of apoptotic chromatin degradation was prevented
by MK801 or by inhibitors of either calpains or caspases (Fig.
8A). This suggests the involvement of a
proteolytic step, downstream to the initial
[Ca2+]i increase, which
results in chromatin breakdown. This proteolytic step does not seem to
be linked to caspase-3 activation. Consistent with the lack of
oligonucleosomal DNA fragmentation and with the proteolysis pattern of
fodrin [caspase-3 forms a 120-kDa fragment, whereas caspase-4,
caspase-2, or calpain forms mainly a 150-kDa fragment (Nath et
al., 1996
)], we did not detect caspase-3-like (DEVD-afc cleavage)
activity in CGC challenged with MPP+. Notably,
DEVD-afc cleavage activity instead was easily detected in the same cell
preparation challenged with colchicine or low [K+] (Leist et al., 1997d
). Further
evidence for the absence of caspase-3 activation in the
MPP+ model is the lack of processing of
procaspase-3 to the active caspase. Procaspase-3 was not cleaved even
at a time point where fodrin was already
90% cleaved and nuclei were
condensed (Fig. 8B).
|
Prevention of MPP+-induced PS translocation by NMDA-R
blockade and caspase inhibition.
Translocation of PS from the
inner to the outer surface of the plasma membrane is an early and
specific event in apoptosis (Leist et al., 1997b
, 1997d
),
which seems to be dependent on caspase activation, at least in tumor
cells. In CGC, MPP+ caused PS translocation, as
detected by annexin V staining, within 1-2 hr.
MPP+-treated neurons stained intensively when the
first signs of chromatin condensation were visible and well before the
nucleus became fully pyknotic. CGC remained stainable for several hours
until membrane permeability was lost and membranes were degraded.
Virtually all neurons with condensed chromatin had lost plasma membrane
lipid asymmetry (
90% annexin V-positive neurons at
MPP+ concentrations of
50 µM in
four independent experiments). Often, large spherical membrane blebs
were formed from the axons, which also stained positively with annexin
V and had an intact membrane. Notably, annexin V binding to neuronal
bodies was completely prevented by MK801 (Fig.
9) and was triggered by direct exposure
to glutamate (not shown), which suggests that PS translocation is
linked to NMDA-R-mediated Ca2+ influx and not to
direct MPP+ actions. In addition, exposure to
rotenone induced PS translocation, which was inhibited by MK801 (Fig.
5B). Annexin V labeling also was inhibited by the caspase inhibitor
z-D-cbk, in agreement with the view that caspases also are
pivotal for this feature of neuronal apoptosis (Fig. 9).
|
| |
Discussion |
|---|
|
|
|---|
MPP+ elicits autocrine excitotoxicity in CGC.
Our
results show that MPP+ induces apoptosis of
cultured CGC by eliciting autocrine excitotoxicity.
MPP+ can induce either apoptosis or necrosis
in vivo (Tatton and Kish, 1997
), and previous studies have
shown that either form of cell death can be induced in
vitro, by mechanisms unrelated to excitotoxicity (Marini et
al., 1989
; Du et al., 1997b
). Low
MPP+ concentrations predominantly elicit
apoptosis, whereas high concentrations trigger necrosis (Hartley
et al., 1994
; Du et al., 1997b
). In animals,
removal of glutamatergic inputs (decortication), blockers of glutamate
release, or NMDA-R antagonists reduce MPTP- and
MPP+-induced striatal damage and dopamine
depletion (Srivastava et al., 1993
) or loss of dopaminergic
neurons in the substantia nigra (Turski et al., 1991
).

and the loss of cytochrome
c were prevented when CGC were pretreated with the NMDA-R
antagonist MK801 (i.e., major components of mitochondrial damage were
the result of secondary excitotoxicity and not the direct effects of
MPP+ on the respiratory chain). In agreement with
this view, low concentrations of four other mitochondrial inhibitors
did not cause massive mitochondrial failure per se (i.e.,
under conditions when the NMDA-R was blocked) but triggered rapid cell
death when the NMDA-R was functional.
Release of NMDA-R agonists in CGC treated with
MPP+ may occur by two different mechanisms
(Szatkowski and Attwell, 1994Mechanisms of indirect excitotoxicity.
Several mechanisms have
been implicated in direct excitotoxic neuronal death, including
excessive NO production and subsequent activation of PARP (Zhang
et al., 1994
), mitochondrial alterations (Ankarcrona
et al., 1995
), and protease activation (Siman and Noszek,
1988
; Du et al., 1997a
). Although brain NO synthase has an
aggravating role in some models of excitotoxicity, NO plays a minor
role as a direct mediator of toxicity in CGC (reviewed in Leist
et al., 1997a
). CGC strongly express nitric oxide synthase and therefore may have developed mechanisms to prevent direct NO
toxicity. Consistent with this assumption, MPP+
toxicity was not altered by nitric oxide synthase inhibitors. PARP
activation is triggered by DNA damage, which may be caused by NO (Zhang
et al., 1994
). We found no alteration in the cell death rate
or mode of cell death in cells prepared from
PARP
/
mice, which further supports the lack
of involvement of NO in MPP+ toxicity. In
contrast, in CGC stimulated with MPP+,
mitochondrial dysfunction and protease activation seem to be key
events, which mediate excitotoxic cell death.
Proteases in excitotoxic death.
Apoptosis is associated with
the activation of a proteolytic cascade, probably involving different
sets of proteases, which operate virtually at all stages of the cell
death program (i.e., signaling, control, and execution) (Villa et
al., 1997
). Here, we found that both caspases and calpains were
activated downstream to the NMDA-R-mediated
[Ca2+]i increase and
upstream of PS translocation, nuclear condensation, and DNA
fragmentation. Under appropriate conditions, cells pretreated with
protease inhibitors survived MPP+ challenge for
several days. Obviously, different sets of proteases can interact to
cause neuronal death; examples include caspases and calpains (Nath
et al., 1996
; Jordán et al., 1997
; current study), different caspases and serine proteases (Stefanis et
al., 1997
), and caspases plus the proteasome.
Excitotoxic apoptosis.
Excitotoxic cell death may occur by
either apoptosis or necrosis. Seemingly divergent observations are
reconciled by the finding that the intensity of insult may determine
the mode of cell death (e.g., Ankarcrona et al., 1995
; Du
et al., 1997a
; Leist and Nicotera, 1998
) and that excessive
Ca2+ entry may convert the mode of cell death in
some cases from apoptosis to necrosis (reviewed in Leist et
al., 1997d
). Intracellular ATP levels seem to be critical in
determining the shape of cell death (Ankarcrona et al.,
1995
; Leist et al., 1997c
), and ATP may be required at
multiple sites. For instance, ATP/dATP is required for the activation
of caspase-3, which is a central protease in many apoptosis models.
Here, we show that apoptosis proceeds in the absence of procaspase-3
processing. This also may explain the lack of oligonucleosomal DNA
fragmentation, which is a direct consequence of caspase-3 activation.
In MPP+-treated neurons, other cell death
proteases may be activated by mechanisms not directly requiring ATP.
| |
Acknowledgments |
|---|
We gratefully acknowledge the excellent technical assistance of
H. Naumann and T. Schmitz We are grateful to Dr. Zhao Qi Wang (IARC,
Lyon, France) for the gift of the PARP
/
mice
and to Dr. C. Montecucco (University of Padova, Padova, Italy) for the
clostridial toxins.
| |
Footnotes |
|---|
Received April 1, 1998; Accepted August 11, 1998
This study was supported by the DFG Grants Ni519/1-1 and Ni519/2-1 and the EEC Grants ENV4-CT96-0169, BMH4CT97-2410, and 12029-97-06 F1ED ISP D.
Send reprint requests to: Dr P. Nicotera, University of Konstanz, Faculty of Biology, Department of Molecular Toxicology, Box X911, D-78457 Konstanz, Germany. E-mail: pierluigi.nicotera{at}uni-konstanz.de
| |
Abbreviations |
|---|
[Ca2+]i, intracellular Ca2+ concentration;

, mitochondrial
membrane potential;
AP5, 5-aminophosphovalerat;
calp II, acetyl-leucyl-leucyl-L-methional;
calp III, z-Val-L-phenylalaninal;
CCCP, carbonylcyanide-chlorophenylhydrazone;
CGC, cerebellar granule cells;
CSS, controlled salt solution;
DCK, 5,7-dichlorokynurenate;
DIV, days
in vitro;
EGTA, ethylene glycol bis(
-aminoethyl
ether)-N,N,N',N'-tetraacetic
acid;
HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid;
DNQX, dinitroquinoxalinedione;
MK801, (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine;
MPP+, 1-methyl-4-phenylpyridinium;
MTT, 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrasodium bromide;
NMDA, N-methyl-D-aspartate;
NMDA-R, N-methyl-D-aspartate receptor;
NO, nitric
oxide;
3-NP, 3-nitropropionic acid;
PARP, poly-(ADP-ribose)polymerase
(E.C. 2.4.2.30);
BoNT/C, botulinum neurotoxin serotype C;
PS, phosphatidylserine;
TMRE, tetramethylrhodamine ethylester;
VDCC, voltage-dependent calcium channel;
z-D-cbk, z-aspartyl-2,6-dichlorobenzoyloxymethylketone.
| |
References |
|---|
|
|
|---|